SILVER SULFADIAZINE

SILVER SULFADIAZINE was reported 2312 times

SILVER SULFADIAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRIDE SYNDROME 6 0.3158
1 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 7 0.1167
2 SKIN GRAFT FAILURE 6 0.0566
3 ANGIOFIBROMA 2 0.0270
4 AUTOINFLAMMATORY DISEASE 5 0.0236
5 APPLICATION SITE NECROSIS 2 0.0194
6 BILIRUBIN CONJUGATED ABNORMAL 2 0.0180
7 ACINETOBACTER BACTERAEMIA 3 0.0160
8 APLASIA CUTIS CONGENITA 2 0.0140
9 SJS-TEN OVERLAP 9 0.0128
10 INTRAOCULAR PRESSURE TEST 3 0.0125
11 LENTIGO 6 0.0121
12 NEONATAL RESPIRATORY DEPRESSION 4 0.0120
13 BACTEROIDES INFECTION 2 0.0077
14 BURNS THIRD DEGREE 8 0.0076
15 WOUND DRAINAGE 6 0.0076
16 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 6 0.0073
17 BRONCHIAL HYPERREACTIVITY 8 0.0067
18 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 4 0.0065
19 GLOMERULOSCLEROSIS 4 0.0063
20 OEDEMA GENITAL 4 0.0063
21 ORAL CAVITY FISTULA 3 0.0061
22 DERMATITIS INFECTED 3 0.0060
23 CATARACT NUCLEAR 4 0.0060
24 HYPERPARATHYROIDISM SECONDARY 13 0.0052
25 LUMBAR RADICULOPATHY 6 0.0052
26 URINARY TRACT INFECTION PSEUDOMONAL 3 0.0050
27 MEDICAL DEVICE SITE INFECTION 3 0.0048
28 NASAL ULCER 7 0.0044
29 COR PULMONALE 4 0.0042
30 MYCOBACTERIUM CHELONAE INFECTION 3 0.0041
31 BLISTER RUPTURE 3 0.0040
32 BLOOD PRESSURE SYSTOLIC ABNORMAL 10 0.0040
33 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
34 DEBRIDEMENT 3 0.0039
35 CORONAVIRUS TEST POSITIVE 4 0.0039
36 BLISTER INFECTED 3 0.0038
37 WOUND COMPLICATION 13 0.0038
38 BONE DEMINERALISATION 4 0.0038
39 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
40 REBOUND ACID HYPERSECRETION 11 0.0036
41 THERMAL BURN 25 0.0035
42 WOUND INFECTION STAPHYLOCOCCAL 6 0.0035
43 NEPHROGENIC ANAEMIA 16 0.0035
44 RADIATION SKIN INJURY 4 0.0034
45 PRIMARY SEQUESTRUM 3 0.0033
46 SKIN GRAFT 3 0.0032
47 FRACTURED SACRUM 4 0.0032
48 LEFT ATRIAL DILATATION 4 0.0031
49 NEUROENDOCRINE CARCINOMA OF THE SKIN 3 0.0031
50 WAIST CIRCUMFERENCE INCREASED 3 0.0029
51 RADIATION INJURY 3 0.0028
52 IRON OVERLOAD 3 0.0028
53 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
54 SEBORRHOEIC KERATOSIS 4 0.0028
55 CARDIAC AMYLOIDOSIS 3 0.0027
56 TOXIC EPIDERMAL NECROLYSIS 41 0.0027
57 CARBON DIOXIDE DECREASED 3 0.0026
58 ACUTE PRERENAL FAILURE 3 0.0026
59 ULCERATIVE KERATITIS 7 0.0026
60 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4 0.0025
61 MITRAL VALVE PROLAPSE 4 0.0024
62 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
63 CUTANEOUS T-CELL LYMPHOMA 3 0.0024
64 SKIN ABRASION 11 0.0023
65 BURNS SECOND DEGREE 4 0.0023
66 RHINITIS ALLERGIC 10 0.0022
67 DECUBITUS ULCER 18 0.0022
68 BLOOD PHOSPHORUS INCREASED 6 0.0022
69 END STAGE RENAL DISEASE 40 0.0022
70 INFUSION SITE RASH 3 0.0022
71 METHAEMOGLOBINAEMIA 5 0.0022
72 PERIPHERAL ARTERY THROMBOSIS 3 0.0021
73 PERIPHERAL ARTERY OCCLUSION 3 0.0021
74 INFECTED SKIN ULCER 4 0.0021
75 FOOT AMPUTATION 3 0.0021
76 SKIN ULCER 51 0.0020
77 EXCORIATION 5 0.0020
78 APPLICATION SITE DISCOLOURATION 8 0.0020
79 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 8 0.0020
80 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
81 WALKING DISABILITY 4 0.0019
82 AORTIC VALVE DISEASE 3 0.0019
83 GANGRENE 11 0.0018
84 DIABETIC NEUROPATHY 9 0.0018
85 MACULE 5 0.0018
86 BLOODY DISCHARGE 2 0.0017
87 EXTREMITY NECROSIS 3 0.0017
88 ALLODYNIA 2 0.0017
89 NECROTISING FASCIITIS 6 0.0017
90 KYPHOSIS 3 0.0017
91 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
92 METABOLIC ENCEPHALOPATHY 5 0.0017
93 ESSENTIAL HYPERTENSION 3 0.0016
94 CALCIPHYLAXIS 3 0.0016
95 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
96 APPLICATION SITE SCAR 2 0.0016
97 SNORING 6 0.0016
98 ECONOMIC PROBLEM 24 0.0016
99 APPLICATION SITE WARMTH 2 0.0016
100 BLOOD BILIRUBIN ABNORMAL 2 0.0016
101 PERIPHERAL VASCULAR DISORDER 8 0.0016
102 POSTURE ABNORMAL 5 0.0015
103 MALNUTRITION 17 0.0015
104 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
105 ANORECTAL DISORDER 3 0.0015
106 CLOSTRIDIAL INFECTION 5 0.0015
107 DERMATITIS PSORIASIFORM 3 0.0015
108 NECROSIS 8 0.0014
109 CHRONIC KIDNEY DISEASE 109 0.0014
110 RENAL FAILURE CHRONIC 11 0.0014
111 HYPERLIPIDAEMIA 17 0.0014
112 AORTIC VALVE INCOMPETENCE 6 0.0014
113 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
114 PYODERMA GANGRENOSUM 5 0.0014
115 MELANOCYTIC NAEVUS 6 0.0014
116 FAILURE TO THRIVE 7 0.0013
117 PSEUDOMEMBRANOUS COLITIS 3 0.0013
118 NEPHROGENIC SYSTEMIC FIBROSIS 4 0.0013
119 LICHENOID KERATOSIS 3 0.0013
120 ECCHYMOSIS 9 0.0013
121 CELLULITIS 66 0.0013
122 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
123 HAEMANGIOMA 3 0.0013
124 PRE-EXISTING CONDITION IMPROVED 8 0.0013
125 WOUND SECRETION 5 0.0013
126 INGROWING NAIL 3 0.0013
127 ORTHOPNOEA 4 0.0013
128 AZOTAEMIA 5 0.0013
129 RADIUS FRACTURE 3 0.0012
130 PROCTALGIA 8 0.0012
131 PERIPHERAL ISCHAEMIA 5 0.0012
132 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
133 ANHEDONIA 32 0.0012
134 LEG AMPUTATION 5 0.0012
135 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0012
136 SYSTEMIC CANDIDA 3 0.0012
137 BLADDER NEOPLASM 2 0.0012
138 PURULENT DISCHARGE 5 0.0012
139 PSEUDOMONAS INFECTION 10 0.0012
140 VARICOSE VEIN 6 0.0012
141 ACUTE SINUSITIS 2 0.0012
142 BLOOD CHLORIDE INCREASED 2 0.0012
143 LIPOMA 3 0.0012
144 SKIN NECROSIS 6 0.0012
145 ACTINIC KERATOSIS 3 0.0012
146 CARDIAC MURMUR 10 0.0012
147 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
148 AORTIC STENOSIS 4 0.0011
149 PAPULE 8 0.0011
150 PHYSICAL DISABILITY 5 0.0011
151 AREFLEXIA 3 0.0011
152 RENAL TUBULAR NECROSIS 11 0.0011
153 OVERWEIGHT 6 0.0011
154 BONE LESION 4 0.0011
155 LIP BLISTER 3 0.0011
156 MONOCYTE COUNT INCREASED 4 0.0011
157 SCLERODERMA 4 0.0011
158 TENOSYNOVITIS 3 0.0011
159 SKIN INFECTION 12 0.0011
160 SKIN DISCOLOURATION 49 0.0011
161 CHRONIC SINUSITIS 4 0.0011
162 SKIN LESION 29 0.0011
163 OXYGEN SATURATION ABNORMAL 3 0.0011
164 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
165 FACE INJURY 4 0.0011
166 FIBULA FRACTURE 3 0.0010
167 FAECAL INCONTINENCE 5 0.0010
168 ENTEROCOCCAL INFECTION 5 0.0010
169 ADENOVIRUS INFECTION 3 0.0010
170 HYPOVOLAEMIA 6 0.0010
171 PURPURA 9 0.0010
172 BREATH SOUNDS ABNORMAL 5 0.0010
173 PROTHROMBIN TIME PROLONGED 6 0.0010
174 MIXED LIVER INJURY 3 0.0010
175 HYPERCAPNIA 3 0.0010
176 MASTICATION DISORDER 3 0.0010
177 BLISTER 54 0.0010
178 BLOOD CREATININE DECREASED 3 0.0010
179 APPLICATION SITE PAIN 21 0.0010
180 ABSCESS LIMB 4 0.0009
181 ANAL FISSURE 5 0.0009
182 APPLICATION SITE VESICLES 6 0.0009
183 HERPES SIMPLEX 6 0.0009
184 LYMPHOCYTE COUNT INCREASED 3 0.0009
185 DIVERTICULUM INTESTINAL 4 0.0009
186 SPINAL OSTEOARTHRITIS 8 0.0009
187 PARONYCHIA 4 0.0009
188 PEPTIC ULCER 3 0.0009
189 HYPOALBUMINAEMIA 7 0.0009
190 THERAPEUTIC AGENT TOXICITY 3 0.0009
191 ANXIETY DISORDER 3 0.0009
192 HEPATIC CYST 3 0.0009
193 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 6 0.0009
194 SCAB 10 0.0009
195 CARDIAC VALVE DISEASE 5 0.0009
196 LYMPHOEDEMA 6 0.0009
197 SYNOVIAL CYST 4 0.0009
198 BREAKTHROUGH PAIN 2 0.0009
199 AUTOIMMUNE HEPATITIS 6 0.0009
200 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
201 CAROTID ARTERY STENOSIS 3 0.0009
202 APPLICATION SITE REACTION 6 0.0009
203 ATELECTASIS 8 0.0008
204 SPONDYLITIS 3 0.0008
205 WOUND INFECTION 9 0.0008
206 BLOOD PHOSPHORUS DECREASED 3 0.0008
207 TOOTH LOSS 17 0.0008
208 FOOD INTOLERANCE 3 0.0008
209 APPLICATION SITE BURN 4 0.0008
210 WOUND HAEMORRHAGE 3 0.0008
211 PIGMENTATION DISORDER 5 0.0008
212 NEURODERMATITIS 3 0.0008
213 BONE DENSITY ABNORMAL 3 0.0008
214 HYPERNATRAEMIA 4 0.0008
215 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
216 PROTEIN TOTAL DECREASED 3 0.0008
217 MITRAL VALVE INCOMPETENCE 9 0.0008
218 PEMPHIGOID 6 0.0008
219 KLEBSIELLA INFECTION 4 0.0008
220 DYSLIPIDAEMIA 4 0.0008
221 WOUND 22 0.0008
222 SLEEP APNOEA SYNDROME 15 0.0008
223 FACIAL PAIN 7 0.0008
224 PHLEBITIS 4 0.0008
225 OESOPHAGEAL ULCER 3 0.0008
226 PRODUCT COLOUR ISSUE 4 0.0008
227 AORTIC ARTERIOSCLEROSIS 2 0.0008
228 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
229 IMPAIRED HEALING 25 0.0008
230 ORAL CANDIDIASIS 10 0.0008
231 OESOPHAGEAL PAIN 3 0.0008
232 POLYDIPSIA 3 0.0008
233 RENAL CYST 6 0.0008
234 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
235 ANIMAL BITE 2 0.0007
236 CANDIDIASIS 3 0.0007
237 LACERATION 7 0.0007
238 ARTERIOSCLEROSIS 7 0.0007
239 SQUAMOUS CELL CARCINOMA 7 0.0007
240 ANAL ABSCESS 4 0.0007
241 RENAL INJURY 22 0.0007
242 PERIPHERAL VENOUS DISEASE 3 0.0007
243 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
244 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
245 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
246 POOR PERIPHERAL CIRCULATION 3 0.0007
247 LUNG NEOPLASM 3 0.0007
248 HIATUS HERNIA 9 0.0007
249 EXERCISE TOLERANCE DECREASED 4 0.0007
250 CHAPPED LIPS 3 0.0007
251 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
252 HAEMORRHAGIC ANAEMIA 3 0.0007
253 CARDIOMYOPATHY 10 0.0007
254 PULMONARY HYPERTENSION 14 0.0007
255 SUNBURN 5 0.0007
256 ATYPICAL PNEUMONIA 2 0.0007
257 OSTEOMYELITIS 12 0.0007
258 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
259 INCONTINENCE 7 0.0007
260 PLATELET COUNT ABNORMAL 4 0.0007
261 BURSITIS 8 0.0007
262 OSTEOPENIA 10 0.0007
263 HAEMOGLOBIN INCREASED 3 0.0007
264 ABDOMINAL HERNIA 3 0.0007
265 BLOOD UREA INCREASED 11 0.0007
266 INJECTION SITE PAPULE 3 0.0007
267 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
268 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
269 UROSEPSIS 6 0.0006
270 DEVICE RELATED INFECTION 10 0.0006
271 BIPOLAR DISORDER 7 0.0006
272 PRODUCT PRESCRIBING ISSUE 14 0.0006
273 THERAPY PARTIAL RESPONDER 10 0.0006
274 YELLOW SKIN 3 0.0006
275 TIBIA FRACTURE 3 0.0006
276 RENAL FAILURE ACUTE 27 0.0006
277 MULTIPLE INJURIES 4 0.0006
278 TRICUSPID VALVE INCOMPETENCE 5 0.0006
279 GINGIVAL PAIN 5 0.0006
280 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
281 HUMERUS FRACTURE 3 0.0006
282 RENAL CELL CARCINOMA 3 0.0006
283 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
284 PANCREATIC DISORDER 3 0.0006
285 STAPHYLOCOCCAL SEPSIS 3 0.0006
286 TOOTH INFECTION 8 0.0006
287 BONE DISORDER 11 0.0006
288 RENAL FAILURE 80 0.0006
289 APPLICATION SITE SWELLING 3 0.0006
290 CARDIAC FAILURE ACUTE 4 0.0006
291 SPINAL PAIN 7 0.0006
292 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
293 PATHOLOGICAL FRACTURE 3 0.0006
294 TOE AMPUTATION 3 0.0006
295 PRODUCT USE IN UNAPPROVED INDICATION 146 0.0006
296 ACUTE KIDNEY INJURY 90 0.0006
297 STEVENS-JOHNSON SYNDROME 13 0.0006
298 WRIST FRACTURE 7 0.0006
299 RIB FRACTURE 12 0.0006
300 PSYCHOLOGICAL TRAUMA 5 0.0006
301 LOCALISED INFECTION 14 0.0006
302 BLOOD CREATININE ABNORMAL 2 0.0006
303 MUSCLE STRAIN 5 0.0006
304 MENTAL STATUS CHANGES 16 0.0006
305 STAPHYLOCOCCAL INFECTION 19 0.0006
306 ACUTE RESPIRATORY FAILURE 11 0.0006
307 POLYARTHRITIS 3 0.0006
308 HYPERCALCAEMIA 7 0.0006
309 HAND FRACTURE 4 0.0006
310 COMPRESSION FRACTURE 3 0.0006
311 ANAL INCONTINENCE 5 0.0006
312 HAEMATOCRIT DECREASED 11 0.0006
313 DERMATITIS BULLOUS 4 0.0006
314 TOOTHACHE 10 0.0006
315 LIMB INJURY 15 0.0006
316 LUPUS-LIKE SYNDROME 5 0.0006
317 RASH PUSTULAR 4 0.0005
318 PATHOGEN RESISTANCE 5 0.0005
319 INTESTINAL ISCHAEMIA 3 0.0005
320 HYPERKERATOSIS 3 0.0005
321 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
322 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
323 CONJUNCTIVITIS 10 0.0005
324 ERYTHEMA MULTIFORME 5 0.0005
325 EYE INFECTION 6 0.0005
326 PERONEAL NERVE PALSY 3 0.0005
327 SCAR 9 0.0005
328 MICTURITION URGENCY 6 0.0005
329 CARDIAC FAILURE CONGESTIVE 42 0.0005
330 BLOOD URIC ACID INCREASED 3 0.0005
331 HYPERCHOLESTEROLAEMIA 5 0.0005
332 SINUS BRADYCARDIA 5 0.0005
333 MUSCULOSKELETAL CHEST PAIN 8 0.0005
334 RALES 3 0.0005
335 HAEMORRHOIDS 10 0.0005
336 HYPERTRIGLYCERIDAEMIA 3 0.0005
337 BONE DENSITY DECREASED 16 0.0005
338 MULTIPLE ALLERGIES 4 0.0005
339 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
340 LYMPHOCYTE COUNT DECREASED 9 0.0005
341 HYPOPHAGIA 13 0.0005
342 HOSPICE CARE 5 0.0005
343 FURUNCLE 4 0.0005
344 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
345 BLEPHARITIS 2 0.0005
346 TYPE 1 DIABETES MELLITUS 3 0.0005
347 LEUKOCYTOSIS 9 0.0005
348 HYPOTHERMIA 5 0.0005
349 SCHIZOPHRENIA 6 0.0005
350 INGUINAL HERNIA 3 0.0005
351 DERMATITIS ACNEIFORM 3 0.0005
352 NEUTROPHIL COUNT INCREASED 5 0.0005
353 CARDIOMEGALY 6 0.0005
354 ESCHERICHIA INFECTION 4 0.0005
355 LIMB DISCOMFORT 15 0.0005
356 SCOLIOSIS 3 0.0005
357 SEPSIS 54 0.0005
358 SKELETAL INJURY 5 0.0005
359 OLIGURIA 3 0.0005
360 HYPOXIA 17 0.0005
361 BACTERIAL INFECTION 9 0.0005
362 HAIR COLOUR CHANGES 6 0.0005
363 INFUSION SITE EXTRAVASATION 3 0.0005
364 VENTRICULAR EXTRASYSTOLES 5 0.0005
365 TENDERNESS 5 0.0005
366 SKIN DISORDER 16 0.0005
367 DERMATITIS 10 0.0005
368 INFUSION SITE SWELLING 3 0.0005
369 MUSCLE ATROPHY 6 0.0005
370 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
371 SKIN HYPERPIGMENTATION 4 0.0005
372 SKIN FISSURES 9 0.0005
373 BACK INJURY 5 0.0005
374 BLOOD PRESSURE FLUCTUATION 11 0.0005
375 URINE OUTPUT DECREASED 4 0.0005
376 SOMNAMBULISM 3 0.0005
377 DENTAL CARIES 5 0.0005
378 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
379 BLOOD CREATINE INCREASED 2 0.0005
380 RESPIRATORY RATE INCREASED 4 0.0005
381 HAIR TEXTURE ABNORMAL 6 0.0004
382 MALIGNANT MELANOMA 6 0.0004
383 GOUT 8 0.0004
384 METASTASES TO LYMPH NODES 3 0.0004
385 POSTOPERATIVE WOUND INFECTION 3 0.0004
386 DRUG TOXICITY 6 0.0004
387 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
388 ULCER 7 0.0004
389 OBESITY 7 0.0004
390 EXOSTOSIS 4 0.0004
391 IRON DEFICIENCY ANAEMIA 4 0.0004
392 LARGE INTESTINE PERFORATION 3 0.0004
393 ARTHRITIS INFECTIVE 2 0.0004
394 PERSONALITY CHANGE 4 0.0004
395 NEPHROPATHY 4 0.0004
396 DUODENAL ULCER 3 0.0004
397 DYSPNOEA EXERTIONAL 16 0.0004
398 OSTEOARTHRITIS 18 0.0004
399 BLOOD SODIUM DECREASED 8 0.0004
400 PHOTOSENSITIVITY REACTION 7 0.0004
401 LYMPHADENOPATHY 15 0.0004
402 FOOT FRACTURE 8 0.0004
403 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
404 RED BLOOD CELL COUNT DECREASED 12 0.0004
405 RASH ERYTHEMATOUS 20 0.0004
406 IMPAIRED QUALITY OF LIFE 6 0.0004
407 POST PROCEDURAL COMPLICATION 8 0.0004
408 OSTEOPOROSIS 17 0.0004
409 EMOTIONAL DISTRESS 50 0.0004
410 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
411 ADRENAL INSUFFICIENCY 5 0.0004
412 INTENTIONAL UNDERDOSE 3 0.0004
413 MAJOR DEPRESSION 3 0.0004
414 OEDEMA PERIPHERAL 50 0.0004
415 OXYGEN SATURATION DECREASED 23 0.0004
416 HYPONATRAEMIA 23 0.0004
417 MUSCLE SPASTICITY 5 0.0004
418 SENSITIVE SKIN 3 0.0004
419 HYPOPHOSPHATAEMIA 3 0.0004
420 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
421 PULMONARY MASS 6 0.0004
422 ILEUS 5 0.0004
423 EPISTAXIS 30 0.0004
424 KETOACIDOSIS 3 0.0004
425 BURNING SENSATION 28 0.0004
426 SECRETION DISCHARGE 5 0.0004
427 HYPERKALAEMIA 14 0.0004
428 INJURY 28 0.0004
429 CORONARY ARTERY DISEASE 12 0.0004
430 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
431 HAEMODYNAMIC INSTABILITY 3 0.0004
432 TOOTH ABSCESS 4 0.0004
433 AMMONIA INCREASED 2 0.0004
434 LIP SWELLING 13 0.0004
435 ROTATOR CUFF SYNDROME 5 0.0004
436 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
437 ANKLE FRACTURE 6 0.0004
438 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
439 DEEP VEIN THROMBOSIS 25 0.0004
440 ANGINA PECTORIS 11 0.0004
441 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
442 DEHYDRATION 51 0.0004
443 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
444 APPLICATION SITE ERYTHEMA 10 0.0004
445 CYANOSIS 6 0.0004
446 BLOOD LACTIC ACID INCREASED 2 0.0004
447 PULMONARY CONGESTION 5 0.0004
448 BLOOD ALBUMIN DECREASED 3 0.0004
449 PRODUCT PRESCRIBING ERROR 9 0.0004
450 HYPOTHYROIDISM 12 0.0004
451 EATING DISORDER 8 0.0004
452 METABOLIC ACIDOSIS 12 0.0004
453 RHINITIS 3 0.0004
454 URINARY INCONTINENCE 11 0.0004
455 RESPIRATORY FAILURE 27 0.0004
456 PHARYNGITIS STREPTOCOCCAL 4 0.0004
457 BACK DISORDER 6 0.0004
458 OEDEMA 20 0.0004
459 HYPOKALAEMIA 17 0.0004
460 PULMONARY EMBOLISM 35 0.0004
461 PROTEINURIA 7 0.0004
462 SKIN LACERATION 4 0.0004
463 POLYURIA 3 0.0004
464 OESOPHAGITIS 4 0.0004
465 BLOOD POTASSIUM DECREASED 11 0.0004
466 METASTASES TO BONE 6 0.0004
467 MULTIPLE FRACTURES 6 0.0004
468 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
469 HAIR DISORDER 3 0.0004
470 INFUSION RELATED REACTION 24 0.0004
471 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
472 GASTROOESOPHAGEAL REFLUX DISEASE 29 0.0004
473 NERVE INJURY 4 0.0004
474 HAEMOPTYSIS 10 0.0004
475 PULMONARY OEDEMA 16 0.0004
476 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
477 PRODUCTIVE COUGH 17 0.0004
478 SENSATION OF FOREIGN BODY 3 0.0004
479 BLOOD CALCIUM DECREASED 4 0.0004
480 SINUS DISORDER 7 0.0004
481 DYSURIA 13 0.0004
482 SINUS TACHYCARDIA 5 0.0004
483 MYOCARDIAL ISCHAEMIA 4 0.0004
484 BRONCHITIS 26 0.0004
485 VITAMIN D DECREASED 3 0.0004
486 DERMATITIS CONTACT 4 0.0004
487 UNRESPONSIVE TO STIMULI 9 0.0003
488 MULTI-ORGAN FAILURE 6 0.0003
489 DELIRIUM 12 0.0003
490 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
491 MADAROSIS 4 0.0003
492 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
493 SKIN EXFOLIATION 29 0.0003
494 NAIL DISORDER 3 0.0003
495 GROIN PAIN 3 0.0003
496 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
497 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
498 COVID-19 PNEUMONIA 4 0.0003
499 ANXIETY 96 0.0003
500 BONE LOSS 5 0.0003
501 ANAEMIA 63 0.0003
502 RESTLESS LEGS SYNDROME 6 0.0003
503 STOMATITIS 20 0.0003
504 NOCTURIA 4 0.0003
505 PRESYNCOPE 8 0.0003
506 HIDRADENITIS 3 0.0003
507 ATRIAL FIBRILLATION 32 0.0003
508 URINARY TRACT INFECTION 56 0.0003
509 JOINT INJURY 7 0.0003
510 PNEUMONIA BACTERIAL 3 0.0003
511 INCREASED TENDENCY TO BRUISE 3 0.0003
512 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
513 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
514 MUSCULOSKELETAL PAIN 17 0.0003
515 SEPTIC SHOCK 14 0.0003
516 APPLICATION SITE IRRITATION 4 0.0003
517 DEFORMITY 3 0.0003
518 INJECTION SITE DISCOLOURATION 4 0.0003
519 FLANK PAIN 3 0.0003
520 PERIPHERAL SWELLING 49 0.0003
521 HYPOCALCAEMIA 6 0.0003
522 PNEUMOTHORAX 5 0.0003
523 MUSCULOSKELETAL DISORDER 6 0.0003
524 TACHYCARDIA 28 0.0003
525 HEART RATE DECREASED 11 0.0003
526 ORAL PAIN 7 0.0003
527 BALANCE DISORDER 27 0.0003
528 INFUSION SITE PAIN 4 0.0003
529 LACTIC ACIDOSIS 10 0.0003
530 BLOOD POTASSIUM INCREASED 5 0.0003
531 VITAMIN D DEFICIENCY 3 0.0003
532 BONE PAIN 18 0.0003
533 RESPIRATORY TRACT INFECTION 8 0.0003
534 KIDNEY INFECTION 6 0.0003
535 NEPHROLITHIASIS 14 0.0003
536 KNEE OPERATION 3 0.0003
537 BODY TEMPERATURE DECREASED 3 0.0003
538 LIGAMENT SPRAIN 3 0.0003
539 VENTRICULAR TACHYCARDIA 5 0.0003
540 C-REACTIVE PROTEIN INCREASED 11 0.0003
541 DIABETES MELLITUS 23 0.0003
542 FEBRILE NEUTROPENIA 20 0.0003
543 HYPOTONIA 3 0.0003
544 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
545 TOXIC SKIN ERUPTION 3 0.0003
546 PLEURAL EFFUSION 18 0.0003
547 DISEASE PROGRESSION 35 0.0003
548 EYE SWELLING 11 0.0003
549 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
550 DISCOMFORT 18 0.0003
551 SLUGGISHNESS 3 0.0003
552 PNEUMONIA 95 0.0003
553 IMPAIRED GASTRIC EMPTYING 4 0.0003
554 HAEMATURIA 10 0.0003
555 DIABETIC KETOACIDOSIS 7 0.0003
556 MUSCULOSKELETAL DISCOMFORT 5 0.0003
557 POOR VENOUS ACCESS 3 0.0003
558 NEURALGIA 7 0.0003
559 ORTHOSTATIC HYPOTENSION 5 0.0003
560 WEIGHT FLUCTUATION 3 0.0003
561 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
562 PRODUCT ODOUR ABNORMAL 3 0.0003
563 NECK PAIN 16 0.0003
564 RASH MACULAR 10 0.0003
565 CARPAL TUNNEL SYNDROME 4 0.0003
566 FALL 95 0.0003
567 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
568 SCRATCH 3 0.0003
569 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
570 SEASONAL ALLERGY 4 0.0003
571 AGEUSIA 7 0.0003
572 BODY HEIGHT DECREASED 3 0.0003
573 PNEUMONIA ASPIRATION 7 0.0003
574 HIP FRACTURE 9 0.0003
575 IRRITABLE BOWEL SYNDROME 6 0.0003
576 SUBDURAL HAEMATOMA 4 0.0003
577 BREAST CANCER METASTATIC 3 0.0003
578 DECREASED ACTIVITY 3 0.0003
579 BLOOD CREATININE INCREASED 18 0.0003
580 FLUID OVERLOAD 4 0.0003
581 GASTROENTERITIS 4 0.0003
582 TOOTH FRACTURE 3 0.0003
583 ACUTE MYOCARDIAL INFARCTION 8 0.0003
584 PSORIATIC ARTHROPATHY 11 0.0003
585 OROPHARYNGEAL PAIN 25 0.0003
586 ARTHROPOD BITE 2 0.0003
587 SKIN HAEMORRHAGE 4 0.0003
588 RASH MACULO-PAPULAR 6 0.0003
589 IMMUNODEFICIENCY 4 0.0003
590 NEPHROPATHY TOXIC 3 0.0003
591 HEPATIC CIRRHOSIS 5 0.0003
592 DERMATITIS ATOPIC 14 0.0003
593 POLLAKIURIA 11 0.0003
594 SINUSITIS 27 0.0003
595 DYSPHAGIA 25 0.0003
596 BACK PAIN 61 0.0003
597 NEOPLASM 3 0.0003
598 LOWER LIMB FRACTURE 5 0.0003
599 PAIN OF SKIN 7 0.0003
600 METASTASES TO LUNG 3 0.0003
601 ATRIOVENTRICULAR BLOCK 2 0.0003
602 ELECTROLYTE IMBALANCE 3 0.0003
603 APHTHOUS ULCER 2 0.0003
604 RENAL DISORDER 12 0.0003
605 VASCULITIS 3 0.0003
606 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
607 PALLOR 7 0.0003
608 APNOEA 2 0.0003
609 CHOKING 5 0.0003
610 ORAL HERPES 5 0.0003
611 SPLENOMEGALY 3 0.0003
612 NASAL CONGESTION 15 0.0003
613 AFFECTIVE DISORDER 2 0.0003
614 ARRHYTHMIA 12 0.0003
615 HAEMOGLOBIN DECREASED 26 0.0003
616 WHEEZING 15 0.0003
617 BLOOD IRON DECREASED 3 0.0003
618 ATAXIA 3 0.0003
619 BACTERAEMIA 3 0.0003
620 DIVERTICULITIS 7 0.0003
621 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
622 HALLUCINATION, AUDITORY 4 0.0003
623 BLOOD PRESSURE ABNORMAL 5 0.0003
624 ACCIDENT 3 0.0003
625 ABSCESS 4 0.0003
626 PAIN 154 0.0003
627 ATRIAL FLUTTER 2 0.0003
628 NIGHT SWEATS 8 0.0002
629 FEEDING DISORDER 5 0.0002
630 DEPRESSION 56 0.0002
631 INTENTIONAL DOSE OMISSION 7 0.0002
632 PAIN IN EXTREMITY 72 0.0002
633 HYPERSOMNIA 7 0.0002
634 SMALL INTESTINAL OBSTRUCTION 3 0.0002
635 OSTEONECROSIS 8 0.0002
636 CONSTIPATION 53 0.0002
637 ABASIA 6 0.0002
638 OSTEONECROSIS OF JAW 6 0.0002
639 GENERALISED OEDEMA 3 0.0002
640 PHARYNGITIS 3 0.0002
641 THROMBOCYTOPENIA 27 0.0002
642 COAGULOPATHY 4 0.0002
643 DYSSTASIA 7 0.0002
644 HYPOTENSION 48 0.0002
645 ASCITES 7 0.0002
646 TREATMENT NONCOMPLIANCE 13 0.0002
647 MOUTH ULCERATION 5 0.0002
648 FACE OEDEMA 4 0.0002
649 DECREASED APPETITE 55 0.0002
650 BLOOD CHOLESTEROL INCREASED 11 0.0002
651 CONFUSIONAL STATE 38 0.0002
652 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
653 LIVER FUNCTION TEST INCREASED 5 0.0002
654 ANOREXIA 3 0.0002
655 ANURIA 2 0.0002
656 HAEMATOMA 6 0.0002
657 FAECES DISCOLOURED 5 0.0002
658 NODULE 3 0.0002
659 RASH 100 0.0002
660 LOCAL SWELLING 4 0.0002
661 ASTHENIA 86 0.0002
662 BEDRIDDEN 3 0.0002
663 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
664 EMOTIONAL DISORDER 7 0.0002
665 EYE HAEMORRHAGE 3 0.0002
666 MUSCLE SPASMS 41 0.0002
667 BLOOD BILIRUBIN INCREASED 6 0.0002
668 APPLICATION SITE PRURITUS 5 0.0002
669 CYSTITIS 7 0.0002
670 WEIGHT DECREASED 61 0.0002
671 SKIN IRRITATION 10 0.0002
672 SHOCK 5 0.0002
673 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
674 HYPERTENSION 46 0.0002
675 MUSCLE TWITCHING 5 0.0002
676 FLUID RETENTION 11 0.0002
677 PLATELET COUNT DECREASED 23 0.0002
678 HYPOMAGNESAEMIA 3 0.0002
679 JOINT SWELLING 26 0.0002
680 CARDIO-RESPIRATORY ARREST 9 0.0002
681 THINKING ABNORMAL 4 0.0002
682 RENAL IMPAIRMENT 18 0.0002
683 CONDITION AGGRAVATED 65 0.0002
684 CHOLELITHIASIS 7 0.0002
685 SLEEP DISORDER 15 0.0002
686 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
687 PAIN IN JAW 6 0.0002
688 DIALYSIS 3 0.0002
689 BLOOD PRESSURE DECREASED 14 0.0002
690 ABDOMINAL PAIN 49 0.0002
691 GASTRIC ULCER 4 0.0002
692 SYNCOPE 21 0.0002
693 DRY SKIN 28 0.0002
694 PARALYSIS 3 0.0002
695 BLOOD PRESSURE INCREASED 32 0.0002
696 CARDIOGENIC SHOCK 3 0.0002
697 TYPE 2 DIABETES MELLITUS 7 0.0002
698 PRESCRIBED OVERDOSE 4 0.0002
699 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
700 FIBROMYALGIA 5 0.0002
701 SURGERY 12 0.0002
702 CEREBRAL INFARCTION 5 0.0002
703 LUNG DISORDER 10 0.0002
704 DYSPEPSIA 20 0.0002
705 MUSCULAR WEAKNESS 23 0.0002
706 DISABILITY 4 0.0002
707 CATARACT 12 0.0002
708 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
709 UPPER LIMB FRACTURE 4 0.0002
710 LEUKOPENIA 10 0.0002
711 SPINAL FRACTURE 4 0.0002
712 ARTHRALGIA 83 0.0002
713 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
714 PANCYTOPENIA 11 0.0002
715 FATIGUE 153 0.0002
716 NEUTROPHIL COUNT DECREASED 8 0.0002
717 INSURANCE ISSUE 3 0.0002
718 COUGH 55 0.0002
719 BODY TEMPERATURE INCREASED 4 0.0002
720 ERYTHEMA 40 0.0002
721 RASH GENERALISED 5 0.0002
722 HYPERGLYCAEMIA 7 0.0002
723 MUCOSAL INFLAMMATION 5 0.0002
724 DYSPNOEA 108 0.0002
725 PRODUCT USE COMPLAINT 3 0.0002
726 HALLUCINATION, VISUAL 4 0.0002
727 VOMITING 89 0.0002
728 NEUROPATHY PERIPHERAL 18 0.0002
729 INJECTION SITE REACTION 13 0.0002
730 RESPIRATORY TRACT CONGESTION 3 0.0002
731 CONTUSION 18 0.0002
732 SENSORY DISTURBANCE 3 0.0002
733 THROMBOSIS 15 0.0002
734 RECTAL HAEMORRHAGE 8 0.0002
735 DYSARTHRIA 7 0.0002
736 DIARRHOEA 120 0.0002
737 INTERSTITIAL LUNG DISEASE 9 0.0002
738 POOR QUALITY SLEEP 4 0.0002
739 SKIN CANCER 4 0.0002
740 OFF LABEL USE 162 0.0002
741 MENTAL DISORDER 8 0.0002
742 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
743 VISION BLURRED 25 0.0002
744 SKIN BURNING SENSATION 13 0.0002
745 RESPIRATORY DISTRESS 5 0.0002
746 FUNGAL INFECTION 6 0.0002
747 ARTHROPATHY 10 0.0002
748 TRANSAMINASES INCREASED 4 0.0002
749 TOOTH DISORDER 4 0.0002
750 INFECTION 26 0.0002
751 PYREXIA 62 0.0002
752 CHILLS 21 0.0002
753 GLOSSODYNIA 4 0.0002
754 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
755 THROAT IRRITATION 8 0.0002
756 PANCREATITIS ACUTE 4 0.0002
757 CANDIDA INFECTION 3 0.0002
758 HEMIPARESIS 3 0.0002
759 HEART RATE IRREGULAR 4 0.0002
760 CIRCULATORY COLLAPSE 3 0.0002
761 NAUSEA 138 0.0002
762 LETHARGY 10 0.0002
763 HYPOAESTHESIA 26 0.0002
764 CHEST PAIN 32 0.0002
765 GAIT DISTURBANCE 33 0.0002
766 SWELLING 16 0.0002
767 METASTASES TO LIVER 3 0.0002
768 COLD SWEAT 3 0.0002
769 RHINORRHOEA 11 0.0002
770 RESPIRATORY DISORDER 5 0.0002
771 MOBILITY DECREASED 12 0.0002
772 BLOOD GLUCOSE DECREASED 8 0.0002
773 LACRIMATION INCREASED 5 0.0002
774 ARTHRITIS 13 0.0002
775 INSOMNIA 44 0.0002
776 ILLNESS 17 0.0002
777 PANIC ATTACK 6 0.0002
778 BLOOD GLUCOSE INCREASED 31 0.0002
779 PRURITUS 63 0.0002
780 ENCEPHALOPATHY 4 0.0002
781 NASOPHARYNGITIS 30 0.0002
782 TREMOR 27 0.0002
783 HAEMORRHAGE 17 0.0002
784 BLOOD GLUCOSE ABNORMAL 3 0.0002
785 HEPATIC STEATOSIS 3 0.0002
786 PHOTOPHOBIA 3 0.0002
787 FRACTURE 3 0.0002
788 BLOOD URINE PRESENT 3 0.0002
789 HEAD INJURY 5 0.0002
790 ALOPECIA 31 0.0002
791 CARDIAC ARREST 13 0.0002
792 MIGRAINE 15 0.0002
793 TREATMENT FAILURE 13 0.0002
794 HERPES ZOSTER 9 0.0002
795 GLAUCOMA 3 0.0002
796 DRUG RESISTANCE 4 0.0002
797 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
798 EAR PAIN 3 0.0002
799 PLASMA CELL MYELOMA 6 0.0002
800 ABDOMINAL DISTENSION 16 0.0002
801 NERVOUSNESS 8 0.0002
802 MEMORY IMPAIRMENT 21 0.0002
803 GASTRITIS 4 0.0002
804 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
805 HEART RATE INCREASED 15 0.0002
806 HYPERSENSITIVITY 28 0.0002
807 BRADYCARDIA 8 0.0002
808 DIZZINESS 75 0.0002
809 EAR INFECTION 4 0.0002
810 PRODUCT PHYSICAL ISSUE 3 0.0001
811 MUSCULOSKELETAL STIFFNESS 13 0.0001
812 ANGER 5 0.0001
813 VERTIGO 9 0.0001
814 NEUTROPENIA 20 0.0001
815 MYALGIA 25 0.0001
816 MOOD ALTERED 4 0.0001
817 ACUTE HEPATIC FAILURE 2 0.0001
818 HALLUCINATION 11 0.0001
819 ABDOMINAL PAIN UPPER 30 0.0001
820 HYPOGLYCAEMIA 7 0.0001
821 PROCEDURAL PAIN 4 0.0001
822 APHONIA 2 0.0001
823 DEATH 123 0.0001
824 TARDIVE DYSKINESIA 4 0.0001
825 RETCHING 3 0.0001
826 HYPOACUSIS 6 0.0001
827 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
828 AMNESIA 9 0.0001
829 SWELLING FACE 9 0.0001
830 ANOSMIA 2 0.0001
831 CRYING 5 0.0001
832 LIVER FUNCTION TEST ABNORMAL 4 0.0001
833 PALPITATIONS 16 0.0001
834 THERAPY CESSATION 7 0.0001
835 AGITATION 10 0.0001
836 ANGIOEDEMA 6 0.0001
837 LABORATORY TEST ABNORMAL 4 0.0001
838 HEPATIC FUNCTION ABNORMAL 5 0.0001
839 RASH PAPULAR 3 0.0001
840 LOSS OF CONSCIOUSNESS 17 0.0001
841 PANCREATITIS 7 0.0001
842 BLOOD COUNT ABNORMAL 2 0.0001
843 URTICARIA 22 0.0001
844 TINNITUS 6 0.0001
845 FEELING HOT 8 0.0001
846 HOSPITALISATION 20 0.0001
847 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
848 WEIGHT INCREASED 29 0.0001
849 FEMUR FRACTURE 4 0.0001
850 COGNITIVE DISORDER 6 0.0001
851 ACUTE MYELOID LEUKAEMIA 2 0.0001
852 SWOLLEN TONGUE 4 0.0001
853 ABNORMAL BEHAVIOUR 5 0.0001
854 DISEASE RECURRENCE 6 0.0001
855 THERAPY INTERRUPTED 9 0.0001
856 INFLUENZA 14 0.0001
857 MULTIPLE SCLEROSIS 6 0.0001
858 MOVEMENT DISORDER 4 0.0001
859 CARDIAC FAILURE 10 0.0001
860 HYPERHIDROSIS 16 0.0001
861 HEADACHE 77 0.0001
862 BLINDNESS 5 0.0001
863 CONVULSION 7 0.0001
864 EYE DISORDER 4 0.0001
865 VISUAL IMPAIRMENT 15 0.0001
866 PARAESTHESIA 19 0.0001
867 EXPIRED PRODUCT ADMINISTERED 4 0.0001
868 DRY EYE 6 0.0001
869 VIRAL INFECTION 4 0.0001
870 SUICIDAL IDEATION 11 0.0001
871 URINARY RETENTION 4 0.0001
872 GAIT INABILITY 4 0.0001
873 DYSPHONIA 7 0.0001
874 ROAD TRAFFIC ACCIDENT 5 0.0001
875 ABDOMINAL DISCOMFORT 20 0.0001
876 EYE PRURITUS 4 0.0001
877 PRODUCT DOSE OMISSION ISSUE 35 0.0001
878 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
879 HAEMATEMESIS 3 0.0001
880 CARDIOVASCULAR DISORDER 3 0.0001
881 PRODUCT QUALITY ISSUE 16 0.0001
882 CHEST DISCOMFORT 12 0.0001
883 ERECTILE DYSFUNCTION 3 0.0001
884 IRRITABILITY 7 0.0001
885 ANAPHYLACTIC SHOCK 3 0.0001
886 INFLAMMATION 6 0.0001
887 ASTHMA 13 0.0001
888 PSORIASIS 15 0.0001
889 SEDATION 3 0.0001
890 SPEECH DISORDER 6 0.0001
891 JOINT STIFFNESS 3 0.0001
892 SOMNOLENCE 23 0.0001
893 DRUG INTOLERANCE 11 0.0001
894 BREAST CANCER FEMALE 3 0.0001
895 MALAISE 49 0.0001
896 GASTROINTESTINAL DISORDER 10 0.0001
897 FEAR 3 0.0001
898 ADVERSE DRUG REACTION 10 0.0001
899 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
900 FREQUENT BOWEL MOVEMENTS 3 0.0001
901 DRY MOUTH 9 0.0001
902 RESTLESSNESS 4 0.0001
903 MYOCARDIAL INFARCTION 19 0.0001
904 HAEMATOCHEZIA 6 0.0001
905 ABNORMAL DREAMS 3 0.0001
906 COVID-19 19 0.0001
907 FEELING COLD 3 0.0001
908 EYE PAIN 6 0.0001
909 CEREBROVASCULAR ACCIDENT 18 0.0001
910 UNEVALUABLE EVENT 8 0.0001
911 EYE IRRITATION 6 0.0001
912 INTENTIONAL PRODUCT MISUSE 9 0.0001
913 HEPATIC ENZYME INCREASED 7 0.0001
914 DISORIENTATION 4 0.0001
915 PREMATURE BABY 3 0.0001
916 APHASIA 3 0.0001
917 THERAPEUTIC RESPONSE DECREASED 6 0.0001
918 EXTRA DOSE ADMINISTERED 4 0.0001
919 BONE MARROW FAILURE 2 0.0001
920 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
921 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
922 FLUSHING 10 0.0001
923 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
924 EXPOSURE DURING PREGNANCY 6 0.0001
925 CARDIAC DISORDER 9 0.0001
926 NERVOUS SYSTEM DISORDER 3 0.0001
927 RHABDOMYOLYSIS 4 0.0001
928 WITHDRAWAL SYNDROME 4 0.0001
929 DRUG INTERACTION 15 0.0001
930 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
931 DYSGEUSIA 7 0.0001
932 MOOD SWINGS 3 0.0001
933 RASH PRURITIC 5 0.0001
934 PRODUCT DOSE OMISSION 6 0.0001
935 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
936 VISUAL ACUITY REDUCED 3 0.0001
937 LIVER DISORDER 4 0.0001
938 MEDICATION ERROR 5 0.0001
939 THERAPY NON-RESPONDER 4 0.0001
940 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
941 RHEUMATOID ARTHRITIS 10 0.0001
942 GASTRIC DISORDER 3 0.0001
943 DRUG INEFFECTIVE 115 0.0001
944 NIGHTMARE 3 0.0001
945 SEIZURE 10 0.0001
946 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
947 COMA 4 0.0001
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
949 ILL-DEFINED DISORDER 5 0.0001
950 ACCIDENTAL OVERDOSE 3 0.0001
951 AGGRESSION 4 0.0001
952 FEELING ABNORMAL 19 0.0001
953 ABDOMINAL PAIN LOWER 2 0.0001
954 NO ADVERSE EVENT 14 0.0001
955 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
956 INJECTION SITE HAEMORRHAGE 6 0.0001
957 NEOPLASM MALIGNANT 5 0.0001
958 PRODUCT USE ISSUE 14 0.0001
959 DRUG EFFECT DECREASED 4 0.0001
960 DYSKINESIA 3 0.0001
961 TOXICITY TO VARIOUS AGENTS 12 0.0001
962 DEVICE MALFUNCTION 5 0.0001
963 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
964 VAGINAL HAEMORRHAGE 3 0.0001
965 DRUG WITHDRAWAL SYNDROME 6 0.0001
966 BLADDER CANCER 4 0.0001
967 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
968 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
969 INJECTION SITE PAIN 19 0.0001
970 ECZEMA 3 0.0001
971 DEVICE ISSUE 5 0.0001
972 DISTURBANCE IN ATTENTION 3 0.0001
973 ADVERSE EVENT 5 0.0001
974 BREAST CANCER 5 0.0001
975 ACNE 4 0.0001
976 INJECTION SITE ERYTHEMA 6 0.0000
977 DRUG ABUSE 4 0.0000
978 OVERDOSE 10 0.0000
979 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
980 INJECTION SITE PRURITUS 3 0.0000
981 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
982 HOT FLUSH 3 0.0000
983 INJECTION SITE SWELLING 3 0.0000
984 DRUG DOSE OMISSION BY DEVICE 3 0.0000
985 INJECTION SITE BRUISING 3 0.0000
986 PROSTATE CANCER 3 0.0000
987 DRUG DOSE OMISSION 6 0.0000
988 ANAPHYLACTIC REACTION 2 0.0000
989 PRODUCT STORAGE ERROR 3 0.0000
990 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
991 DRUG DEPENDENCE 5 0.0000
992 INCORRECT DOSE ADMINISTERED 6 0.0000